Publications

Corporate Headquarters

440 Stevens Avenue, Suite 200 Solana Beach, CA 92075
Tel: (858) 224-1000

Find Us On

Organovo is collaborating with the University of Virginia to develop 3D bioprinted tissues for volumetric muscle loss injury

GO BACK

Publication Summary:

Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a collaboration with the University of Virginia to develop 3D bioprinted tissues for volumetric muscle loss (“VML”) injury. The research will take place in the laboratory of George J. Christ, Ph.D., professor of biomedical engineering and orthopaedic surgery at UVA.

View Publication  
Publication Thumbnail Image